Plasma porphyrins in the porphyrias

Clinical Chemistry

Volumn 45, Issue 7, 1999, Pages 1070-1076

  Hindmarsh, J Thomas ^a   Oliveras, Linda ^a   Greenway, Donald C ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL GROUP; COPROPORPHYRIN; PORPHYRIN; UROPORPHYRIN;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PORPHYRIA VARIEGATA;

EID: 0032789362     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.7.1070     Document Type: Article

References (30)

1. Elder GH, Smith SG, Smyth SJ. Laboratory Investigation of the porphyrias. Ann Clin Biochem 1990;27:395-412.
2. Ratnaike S, Blake D. The diagnosis and follow-up of porphyria. Pathology 1995;27:142-53.
3. Elder GH. Genetic defects in the porphyrias. Clin Dermatol 1998;16:225-33.
4. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory: approved guideline. NCCLS document C28-A. Villanova, PA: NCCLS, 1995.
5. Kennedy SW, James CA. Improved method to extract and concentrate porphyrins from liver tissue for analysis by high-performance liquid chromatography. J Chromatogr 1993;619:127-32.
6. Johnson PM, Perkins SL, Kennedy SW. A high speed liquid-chromatographic method for measuring urine porphyrins. Clin Chem 1988;34:103-5.
7. Pudek M, Schreiber WE, Jamani A. Quantitative fluorometric screening test for fecal porphyrins. Clin Chem 1991;37:826-31.
8. Piomelli S. Free erythrocyte porphyrins in the detection of undue absorption of Pb and of Fe deficiency. Clin Chem 1977;23:264-9.
9. Piepkorn MW, Hamernyik P, Labbé RF. Modified erythrocyte uroporphyrinogen I synthase assay, and its clinical interpretation. Clin Chem 1978;24:1751-4.
10. Kalb RE, Grossman ME, Poh-Fitzpatrick M. Correlation of serum and urinary porphyrin levels in porphyria cutanea tarda. Arch Dermatol 1985;121:1289-91.
11. Carson RW, Dunnigan EJ, DuBose TD, Goeger DE, Anderson KE. Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease. J Am Soc Nephrol 1992;2:1445-50.
12. De Salamanca RE, Sepulveda P, Moran MJ, Santos JL, Fontanellas A, Hernandez A. Clinical utility of fluorometric scanning of plasma porphyrins for the diagnosis and typing of porphyrias. Clin Exp Dermatol 1993;18:128-30.
13. Long C, Smyth SJ, Woolf J, Murphy GM, Finlay AY, Newcombe RG, et al. Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol 1993;129:9-13.
14. Jacob K, Doss MO. Excretion pattern of fecal coproporphyrin Isomers I-IV in human porphyrias. Eur J Clin Chem Clln Biochem 1995;33:893-901.
15. Moore MR, Turnbull AL, Barnardo D, Beattie AD, Magnus IA, Goldberg A. Hepatic delta aminolevulinic acid synthetase activity in porphyria cutanea tarda. Lancet 1972;2:97-101.
16. Poh-Fitzpatrick MB, Masullo AS, Grossman ME. Porphyria cutanea tarda associated with chronic renal disease and hemodialysis. Arch Dermatol 1980;116:191-5.
17. Seubert S, Seubert A, Rumpf KW, Kiffe H. A porphyria cutanea tarda-like distribution pattern of porphyrins in plasma, hemodialysate, hemofiltrate, and urine of patients on chronic hemodialysis. J Investig Dermatol 1985;85:107-9.
18. Anderson KE, Golger DE, Carson RW, Lee SK, Stead RB. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long term hemodialysis. N Engl J Med 1990;322:315-7.
19. Poh-Fitzpatrick MB, Sosin AE, Bemis J. Porphyrin levels in plasma and erythrocytes of chronic hemodialysis patients. J Am Acad Dermatol 1982;7:100-4.
20. Gafter U, Mamet R, Korzets A, Malachi T, Schoenfeld N. Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium. Nephrol Dial Transplant 1996;11:1787-91.
21. Gebril M, Weinkove C, Ead R, McDonald K, Morton R. Plasma porphyrins in chronic renal failure. Nephron 1990;55:159-63.
22. Day RS, Eales L. Porphyrins in chronic renal failure. Nephron 1980;26:90-5.
23. Siersema PD, de Rooij FWM, Edixhoven-Bosdijk A, Weimer W, Wilson JHP. Heme synthesis in chronic renal failure: the effects of hemodialysis, peritoneal dialysis and erythropoietin treatment. Nephron 1995;71:297-302.
24. Harber LC, Bickers DR. Porphyria and pseudoporphyria. J Investig Dermatol 1984;82:207-9.
25. Kappas A, Sassa S, Galbraith RA, Nordmann Y. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 7th ed. New York: McGraw-Hill, 1995:2125.
26. Bonkowsky HL, Schady, W. Neurological manifestations in acute porphyria. Semin Liver Dis 1982;2:108-24.
27. Moran JM, Fontanellas A, Santos JL, de Salamanca RE. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda. Int J Biochem Cell Biol 1995;27:585-8.
28. Longas MO, Poh-Fitzpatrick MB. A tightly bound protein-porphyrin complex isolated from the plasma of a patient with variegate porphyria. Clin Chim Acta 1982;118:219-28.
29. Poh-Fitzpatrick MB. A plasma porphyrln fluorescence marker for variegate porphyria. Arch Dermatol 1980;116:543-7.
30. Da Silva V, Simonin S, Deybach JC, Puy H, Nordmann Y. Variegate porphyria; diagnostic value of fluorometric scanning of plasma porphyrins. Clin Chim Acta 1995;238:163-8.